Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8


Mitochondrial DNA Mutations are Associated with Ulcerative Colitis Preneoplasia but Tend to be Negatively Selected in Cancer.

Baker KT, Nachmanson D, Kumar S, Emond MJ, Ussakli C, Brentnall TA, Kennedy SR, Risques RA.

Mol Cancer Res. 2019 Feb;17(2):488-498. doi: 10.1158/1541-7786.MCR-18-0520. Epub 2018 Nov 16.


Concordance study of PD-L1 expression in primary and metastatic bladder carcinomas: comparison of four commonly used antibodies and RNA expression.

Tretiakova M, Fulton R, Kocherginsky M, Long T, Ussakli C, Antic T, Gown A.

Mod Pathol. 2018 Apr;31(4):623-632. doi: 10.1038/modpathol.2017.188. Epub 2017 Dec 22.


Serous versus high-grade endometrioid endometrial carcinoma: immunohistochemistry of RFP is not useful for differentiation.

Ussakli C, Usubutun A, Dincer N, Dolgun A, Bülbül D, Isikdogan Z, Haberal N, Ozen O, Tezel GG.

Pol J Pathol. 2016;67(3):221-227. doi: 10.5114/pjp.2016.63773.



Risques RA, Ussakli C, Salk JJ, Rabinovitch PS, Brentnall TA.

J Natl Cancer Inst. 2014 Feb;106(2):djt437. doi: 10.1093/jnci/djt437. Epub 2014 Jan 8. No abstract available.


Clonal expansions and short telomeres are associated with neoplasia in early-onset, but not late-onset, ulcerative colitis.

Salk JJ, Bansal A, Lai LA, Crispin DA, Ussakli CH, Horwitz MS, Bronner MP, Brentnall TA, Loeb LA, Rabinovitch PS, Risques RA.

Inflamm Bowel Dis. 2013 Nov;19(12):2593-602. doi: 10.1097/MIB.0b013e3182a87640.


Mitochondria and tumor progression in ulcerative colitis.

Ussakli CH, Ebaee A, Binkley J, Brentnall TA, Emond MJ, Rabinovitch PS, Risques RA.

J Natl Cancer Inst. 2013 Aug 21;105(16):1239-48. doi: 10.1093/jnci/djt167. Epub 2013 Jul 12.


Prognostic value of ERG oncoprotein in prostate cancer recurrence and cause-specific mortality.

Spencer ES, Johnston RB, Gordon RR, Lucas JM, Ussakli CH, Hurtado-Coll A, Srivastava S, Nelson PS, Porter CR.

Prostate. 2013 Jun;73(9):905-12. doi: 10.1002/pros.22636. Epub 2013 Jan 17.


Stem cell-related markers in primary breast cancers and associated metastatic lesions.

Guler G, Balci S, Costinean S, Ussakli CH, Irkkan C, Suren D, Sari E, Altundag K, Ozisik Y, Jones S, Bacher J, Shapiro CL, Huebner K.

Mod Pathol. 2012 Jul;25(7):949-55. doi: 10.1038/modpathol.2012.37. Epub 2012 Mar 2.

Supplemental Content

Loading ...
Support Center